CTLA4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky SCID

CTLA4-Ig controls immune dysregulation in an Artemis deficient mouse model that recapitulates leaky SCID/ Omenn Syndrome clinical manifestations.

http://ift.tt/2kfm74g